Network abnormalities among non-manifesting Parkinson disease related LRRK2 mutation carriers.

Journal: Human brain mapping
PMID:

Abstract

Non-manifesting carriers (NMC) of the G2019S mutation in the LRRK2 gene represent an "at risk" group for future development of Parkinson's disease (PD) and have demonstrated task related fMRI changes. However, resting-state networks have received less research focus, thus this study aimed to assess the integrity of the motor, default mode (DMN), salience (SAL), and dorsal attention (DAN) networks among this unique population by using two different connectivity measures: interregional functional connectivity analysis and Dependency network analysis (D NA). Machine learning classification methods were used to distinguish connectivity between the two groups of participants. Forty-four NMC and 41 non-manifesting non-carriers (NMNC) participated in this study; while no behavioral differences on standard questionnaires could be detected, NMC demonstrated lower connectivity measures in the DMN, SAL, and DAN compared to NMNC but not in the motor network. Significant correlations between NMC connectivity measures in the SAL and attention were identified. Machine learning classification separated NMC from NMNC with an accuracy rate above 0.8. Reduced integrity of non-motor networks was detected among NMC of the G2019S mutation in the LRRK2 gene prior to identifiable changes in connectivity of the motor network, indicating significant non-motor cerebral changes among populations "at risk" for future development of PD.

Authors

  • Yael Jacob
    Translational and Molecular Imaging Institute, Icahn School of Medicine, Mount Sinai Medical Center, New York, New York.
  • Keren Rosenberg-Katz
    Sagol Brain Institute Tel-Aviv Medical Center, Tel-Aviv, Israel.
  • Tanya Gurevich
    Sagol Brain Institute Tel-Aviv Medical Center, Tel-Aviv, Israel.
  • Rick C Helmich
    Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.
  • Bastiaan R Bloem
    Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.
  • Avi Orr-Urtreger
    Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Nir Giladi
    The Center for the Study of Movement, Cognition and Mobility, Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Anat Mirelman
    Sagol Brain Institute Tel-Aviv Medical Center, Tel-Aviv, Israel.
  • Talma Hendler
    Functional Brain Center.
  • Avner Thaler
    Sagol Brain Institute Tel-Aviv Medical Center, Tel-Aviv, Israel.